Oman - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Oman Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was down by 9% year on year. At 5 Cases in 2019, the country was ranked number 276 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India topped the ranking with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 5.00 |
| 2018 | 5.00 |
| 2017 | 0.00 |
| 2016 | 6.00 |
| 2015 | 4.00 |
Download all data from 2005 to 2019
How does Oman rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 276 |
#276
New Zealand
|
5 | 2017 | NA | +4.6 % | View data | |
| 276 |
#276
Oman
|
5 | 2019 | +0.0 % | -9.0 % | View data | |
| 276 |
#276
Timor-Leste
|
5 | 2019 | +0.0 % | +10.8 % | View data | |